
Bio Vitos Pharma Investor Relations Material
Latest events

Q4 2024
28 Feb, 2025

Q3 2024
15 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bio Vitos Pharma
Access all reports
Bio Vitos Pharma AB, previously known as Hemcheck Sweden AB, is a medical technology company based in Sweden. The company specializes in developing and commercializing solutions for the detection of hemolysis in blood samples. Their primary product is a combination of disposable tests and readers designed to quickly identify hemolyzed blood samples in vacuum tubes and blood gas syringes. This technology aims to enhance patient safety, streamline healthcare processes, and reduce costs by ensuring accurate blood sample analysis. Bio Vitos Pharma serves the healthcare sector, particularly targeting emergency departments in Europe and the United States. The company is headquartered in Solna, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
BIOVIT
Country
🇸🇪 Sweden